Rare
lephants
Screener
Toggle theme
Schrodinger, Inc.
SDGR
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2020
Total Cash from Operations:
$109.8M
Line Item
Value
% of Total
Working Capital
$35.1M
32.0%
Net Cash Flow
$74.7M
68.0%
Download CSV
